$15/user for an eQMS — what actually changes for small medtech teams

I started paying attention when a freind-of-a-friend sent a pricing screenshot: "$15/user". For a two-person RA/QA team juggling MDR Technical Files, PMCF plans, and a creeping CAPA backlog, the headline feels different to a CFO than to an engineer. I’ve worked on several eQMS rollouts for SMEs; here’s what $15/user buys in practice, what it doesn’t, and the decisions you still have to make.

What $15/user really enables (the baseline)

In my experience, moving from ad-hoc spreadsheets and shared drives to a paid eQMS at roughly this price point removes the single biggest friction: fragmentation. For a small manufacturer, that matters because regulatory work is a flow problem as much as a documentation problem.

At this level you can generally expect:

• Core document control with versioning and electronic signatures (audit trail, sign-off workflows).
• Role-based access and seat management — important when your team is two people plus three contractors.
• Basic CAPA workflows with templates for root cause and corrective actions; email notifications and due-date tracking.
• Traceability between documents, changes, and CAPAs — the minimal links auditors want to see for Technical File traceability.
• Cloud hosting and regular maintenance/patching handled by the vendor (check data residency).

These are the things that stop the “where is that risk assessment?” game during audits. To be fair, they won’t fix a broken process, but they make the work discoverable and reviewable — the core of compliance.

What still costs extra (and often surprises teams)

$15/user is an attractive headline but there are common extras that matter far more than a price-per-seat number:

• Implementation and configuration. You still need someone to map your processes to the tool, set up roles, and build your document hierarchy. SMEs frequently underestimate this effort.
• Migration of legacy files and traceability links. Automating import is rarely seamless; expect manual clean-up.
• Validation evidence. Per ISO 13485 and applicable MDR expectations, the manufacturer is responsible for eQMS validation. The vendor may provide validation support packs, but you will need to run and document IQ/OQ/PQ activities relevant to your use.
• Integrations (PLM, ERP, MES, CAD). If you need linked BOMs or design files in the Technical File, integrations add cost.
• Premium modules: advanced change impact analysis, formal PMCF workflows, supplier quality portals, or AI-assisted features often sit behind higher tiers.

In short: the monthly seat price is one part of total cost of ownership. Migration and validation frequently dominate first-year costs.

Features that justify paying for $15/user (from an RA perspective)

When I evaluate eQMS options for medtech SMEs preparing for MDR audits, I look for these capabilities — because they reduce audit risk and inspection time:

• End-to-end traceability: document → design change → risk assessment → verification → CAPA. If you can run a trace report for an Annex II element, you win.
• Change impact analysis across the Technical File. Not just a checkbox but a connected workflow that surfaces affected documents and open actions.
• PMCF / PSUR workflow templates with versioned datasets and review logs. Not all vendors get post-market surveillance ergonomics right.
• Configurable CAPA with automated CAPA-driven risk assessment steps and review gates. Automated CAPAs are useful only if they force quality thinking, not replace it.
• Reviewability and audit trail: every decision should be explainable, and the system should make that explanation retrievable.
• Exportable evidence for notified bodies and EUDAMED submissions (I’m speaking from the trenches — EUDAMED’s UDI module still requires pragmatic exports).

If the $15 tier includes even two or three of those well-implemented features, it’s a good deal for a small medical device shop.

The human factor: adoption matters more than price

A cheap eQMS that people avoid is a compliance liability. I’ve seen teams buy cheap seats and then revert to email attachments because the tool didn’t fit their workflow. A few practical tips:

• Start with a pilot team and one validated process (e.g., CAPA) rather than flipping everything at once.
• Distinguish power users from viewers. You probably don’t need a licence for every reviewer; read-only accounts or lower-cost viewers reduce seat costs.
• Invest in training that’s scenario-based: “how to close a CAPA under MDR expectations” beats vendor feature demos.
• Keep the ROI metric practical: time-to-audit-readiness, number of late CAPAs, and the time engineers spend answering document requests.

Naja, people underestimate change management. It’s still the hard part.

Where the $15 promise can mislead

Some vendors use the per-user price to distract from missing obligations you still carry:

• Validation: vendor claims “validated platform” are helpful but don’t replace your documented validation of intended use and configuration.
• Regulatory nuance: tools can help map documents to Annex II items, but they won’t produce a compliant clinical evaluation or PMCF plan for you.
• AI features: nice to have, but AI-assisted CAPA suggestions must remain controlled assistance with human review; auditors will want to see the decision trail.

Genau — the system helps. It doesn’t replace competent regulatory judgement.

Practical checklist before you sign up

Ask these questions before you click buy:

• How does the vendor support eQMS validation? Do they provide test scripts and evidence packs?
• Can I export full Technical File traces in a human-readable format?
• What counts as a “user”? Are reviewers charged the same as power users?
• Where are the servers located, and how does that affect data residency and the Swiss/EU context?
• Which premium features matter to my MDR obligations (PMCF workflows, change impact mapping, supplier portals)?

Final thought

$15/user lowers the financial barrier for SMEs to run a proper QMS. But the tactical wins come from configuration, validation, and adoption. If you treat the price as the headline and not the project plan, you’ll still be firefighting in six months.

What was the biggest non-price surprise your team encountered when you moved to an eQMS?